收藏切换
Progress of Rhubarb and its Drug Pair
收藏切换
Yunfei ZHENG1, 2, Zeshan CHEN3, Xin DENG1
Chinese Archives of Traditional Chinese Medicine | 2026, 44(5) : 204 - 210
Less
收藏切换
Chinese Archives of Traditional Chinese Medicine | 2026, 44(5): 204-210
• Target on National Project •
Progress of Rhubarb and its Drug Pair
Full
Yunfei ZHENG1, 2, Zeshan CHEN3, Xin DENG1
Affiliations
  • 1. Guangxi University of Chinese Medicine, Nanning 530000, Guangxi, China
  • 2. Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning 530000, Guangxi, China
  • 3. People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530000, Guangxi, China
Published: 2026-05-10 doi: 10.13193/j.issn.1673-7717.2026.05.037
Outline
收藏切换

Rhubarb is one of the commonly used drugs in clinic, which is a good medicine for purging fire and laxative, cooling blood and detoxification. This paper summarizes the effective components of anthraquinones, anthrones, rhein, emodin and chrysophanol. In clinical application, rhubarb and its drug pairs have different mechanisms in the treatment of various diseases. It has pharmacological effects such as regulating gastrointestinal tract, anti-tumor, anti-fibrosis, anti-inflammation and anti-oxidation, involving Wnt1/β-catenin, AMPK/TXNIP/NLRP3, TLR4/NF-κB/c-myc and other signaling pathways. In clinical application, rhubarb is often combined with Danshen, Taoren, Huanglian, Huangqi, Mahuang, Fuzi and other drugs, which has a certain effect on chronic kidney disease, adenomyosis, diabetes, pneumonia and other diseases. According to the different processing methods, the pharmacological effects of rhubarb change with the content of anthraquinone glycosides and monomer tannins. Modern research shows that the chemical composition of rhubarb before and after compatibility has a significant change. When the ratio of rhubarb to Salvia miltiorrhiza, Gardenia jasminoides, Centella asiatica, and Astragalus is 1∶2, 1∶1, 1∶5, 1∶1, respectively, it can maximize the drug efficacy, reduce toxic and side effects, and improve the effectiveness and safety of medication. This article focuses on the pharmacological effects of rhubarb and its compatibility research in network pharmacology, clinical compatibility application, and chemical composition changes before and after compatibility, in order to provide reference for the further development and utilization of rhubarb and its drug pairs, in order to better play the clinical value of traditional Chinese medicine rhubarb.

rhubarb  /  drug pair  /  pharmacological effects  /  clinical compatibility
郑云飞, 陈泽山, 邓鑫. 大黄及其药对的研究进展. 中华中医药学刊, 2026 , 44 (5) : 204 -210 . DOI: 10.13193/j.issn.1673-7717.2026.05.037
Yunfei ZHENG, Zeshan CHEN, Xin DENG. Progress of Rhubarb and its Drug Pair[J]. Chinese Archives of Traditional Chinese Medicine, 2026 , 44 (5) : 204 -210 . DOI: 10.13193/j.issn.1673-7717.2026.05.037
Year 2026 volume 44 Issue 5
67
12
Cite this Article
BibTeX
Article Info
doi: 10.13193/j.issn.1673-7717.2026.05.037
  • Online Date:2026-10-14
  • Published:2026-05-10
Article Data
Affiliations
History
Funding
Affiliations
    1. Guangxi University of Chinese Medicine, Nanning 530000, Guangxi, China
    2. Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning 530000, Guangxi, China
    3. People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530000, Guangxi, China
References
Share
https://castjournals.cast.org.cn/joweb/zhzyyxk/EN/10.13193/j.issn.1673-7717.2026.05.037
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT